Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

Affidea exits all operations in Hungary

Pan-European diagnostics and outpatient group Affidea is selling all of its Hungarian operations to Medicare Group, a Hungary-based private healthcare provider, marking a full exit from the country where it was founded in 1991.
April 16, 2026

Polypeptide Group attracts takeover interest from private equity firms

Polypeptide Group, a listed Switzerland-based contract development and manufacturing organisation (CDMO) serving pharmaceutical and biotech companies, has attracted takeover interest from private equity investors. The company specialises in peptide-based active pharmaceutical ingredients (APIs) and operates manufacturing sites across the United States, Europe, and India.
April 16, 2026

H.I.G. Capital-backed Vernacare buys Eakin Surgical

Vernacare, a manufacturer of single-use medical devices and healthcare consumables backed by private equity firm H.I.G. Capital has acquired Eakin Surgical Limited from Eakin Healthcare Group, a family-owned medical device company. Eakin Surgical is a UK-based manufacturer of single-use surgical instruments.
April 16, 2026

HBI 2026: Creating value in changing times, from reactive to preventive

Healthcare systems across the world are under pressure from rising demand, ageing populations, and constrained resources. As a result, the definition of “value” in healthcare is being re-examined. Traditionally, value has meant achieving better outcomes at lower cost. At HBI 2026, a panel featuring Dimitris Moulavasilis, Group CEO at Abu Dhabi-based healthcare company M42; Pascal […]
April 16, 2026

Novo Nordisk partners with OpenAI

Danish drug maker Novo Nordisk has partnered with the American AI research organisation OpenAI to embed AI across drug development and operations, treating it as part of everyday workflows rather than a standalone project.
April 16, 2026

Revenio acquires Visionix expanding into OCT market

Revenio, a Finnish company specialising in ophthalmic diagnostics and software, has bought Visionix, a French ophthalmic technology group. The transaction values Visionix at an enterprise value of €290 million.
April 16, 2026

2025 saw highest ever residential elderly care real estate investment in Europe

2025 was a record year for investment into European care real estate, with a total of over €14 billion invested according to data from real estate broker Cushman and Wakefield. However, about half of this came from a single US REIT, Welltower, buying up a large chunk of the UK's care infrastructure.
April 13, 2026

HBI Deals+Insights briefing April 2026: Intelligence members

HBI’s April 2026 monthly edition includes HBI’s first ever Healthcare Property Investors Ranking 2026 edition, tracking the main players investing in European healthcare real estate. It also includes the HBI first ever CEO Survey based on responses from C-suite leaders across healthcare organisations.
April 13, 2026
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us